Zapping the esophagus: an implantable device takes on chronic heartburn

NCT ID NCT02749071

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether a small implanted device that electrically stimulates the lower esophageal sphincter can reduce acid reflux in people with GERD. Participants receive either active stimulation or a sham (inactive) device for six months, then all receive stimulation. The study measures changes in esophageal acid exposure and symptom improvement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an implanted device that electrically stimulates the lower esophageal sphincter
What this could lead to
If it works, this could offer a long-term, drug-free option for controlling GERD symptoms and reducing acid exposure.
What could go wrong
This is an early-stage trial with a sham control, so the real benefit is still uncertain. The device requires surgery to implant, which carries risks like infection or device-related complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACID REFLUX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Allegheny Health Network Research Institute

    Pittsburgh, Pennsylvania, 15224, United States

  • Baylor Scott & White Research Institute

    Round Rock, Texas, 78665, United States

  • Carolinas HealthCare System

    Charlotte, North Carolina, 28260, United States

  • Clinical Trial Center Maastricht

    Maastricht, Netherlands

  • Columbia University Medical Center

    New York, New York, 10032, United States

  • Cornell University Weill Medical College

    New York, New York, 10021, United States

  • HonorHealth Research Institute

    Scottsdale, Arizona, 85258, United States

  • Institute of Esophageal and Reflux Surgery

    Englewood, Colorado, 80113, United States

  • Oregon Clinic

    Portland, Oregon, 97213, United States

  • Oregon Health Science University

    Portland, Oregon, 97239, United States

  • St. Joseph's Hospital and Medical Center

    Phoenix, Arizona, 85013, United States

  • Stanford Center for Clinical Research

    Stanford, California, 94305, United States

  • The MetroHealth System

    Cleveland, Ohio, 44109, United States

  • The Ohio State University Medical Center

    Columbus, Ohio, 43210, United States

  • Universitaire Ziekenhuizen Leuven

    Leuven, Belgium

  • University College London

    London, United Kingdom

  • University of North Carolina

    Chapel Hill, North Carolina, 27599, United States

  • University of South Florida

    Tampa, Florida, 33606, United States

  • University of Southern California (USC)

    Los Angeles, California, 90033, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37212, United States

  • Virginia Commonwealth University

    Richmond, Virginia, 23298, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.